Carzomib 60mg Injection
Marketer
Hetero Healthcare Limited
Salt Composition
Carfilzomib (60mg)
Overview Carzomib 60mg Injection
Kyprolis 60mg Injection is indicated for the management of multiple myeloma. Its mechanism of action involves inhibiting or retarding the proliferation of malignant cells. Administration is via intravenous injection by a healthcare professional. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for several weeks or months; discontinue use only as directed by your physician. Common adverse events include tiredness, vomiting, and elevated temperature. This medication can decrease blood cell counts (red and white blood cells), potentially increasing vulnerability to infections. Report any fever, shivering, musculoskeletal pain, facial flushing or edema, or chest discomfort to your doctor immediately. Maintain adequate hydration during treatment. Prior to commencing treatment, inform your physician of any pre-existing cardiac, hepatic, or renal conditions, or the use of any antimicrobial agents. Significant drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Uses of Carzomib 60mg Injection
Plasma cell malignancy
Major Benefits of Carzomib 60mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Carzomib 60mg Injection:
- Fatigue
- Anemia (low number of red blood cells)
- Nausea
- Low blood platelets
- Fever
How to use Carzomib 60mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Carzomib 60mg Injection works:
Carzomib 60mg Injection is an anticancer drug that inhibits proteasome function. This action prevents the degradation of cellular proteins, causing a build-up of proteins within cancer cells and ultimately inducing apoptosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carzomib 60mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carzomib 60mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated, except in exceptionally rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Breastfeeding is contraindicated while using Carzomib 60mg Injection due to the potential for infant toxicity.
DrivingUNSAFE
The administration of Carzomib 60mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Refrain from operating a vehicle if any of these effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should receive Carzomib 60mg Injection with careful monitoring. Dosage modification of Carzomib 60mg Injection might be necessary; physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should receive Carzomib 60mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Carzomib 60mg Injection :
NA
Facts to Know About Carzomib 60mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Epoxomicin Analog |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Proteasome inhibitor |
3,018 People bought this recently